FIBRILLARY GLOMERULONEPHRITIS

Clinical trials for FIBRILLARY GLOMERULONEPHRITIS explained in plain language.

Never miss a new study

Get alerted when new FIBRILLARY GLOMERULONEPHRITIS trials appear

Sign up with your email to follow new studies for FIBRILLARY GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare kidney disease? drug trial targets protein leak

Disease control Recruiting now

This study tests if the drug obinutuzumab can safely reduce protein in the urine of people with fibrillary glomerulonephritis, a rare kidney condition. About 20 adults with confirmed disease and significant protein leakage will receive the drug and be monitored for a year. The go…

Matched conditions: FIBRILLARY GLOMERULONEPHRITIS

Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

FIBRILLARY GLOMERULONEPHRITIS

Get alerted when new FIBRILLARY GLOMERULONEPHRITIS trials appear

New hope for rare kidney disease? drug trial targets protein leak